Some Staphylococcus aureus bacteria are thought to survive standard antibiotic treatment by 'hiding' in host cells. But an antibody–antibiotic conjugate has been developed that targets these bacteria in mouse models. See Article p.323
Notes
References
Lehar, S. M. et al. Nature 527, 323–328 (2015).
World Health Organization. Antimicrobial Resistance: Global Report on Surveillance (WHO, 2014).
Lewis, K. Annu. Rev. Microbiol. 64, 357–372 (2010).
Giang, I., Boland, E. L. & Poon, G. M. K. AAPS J. 16, 899–913 (2014).
Joller, N. et al. Proc. Natl Acad. Sci. USA 107, 20441–20446 (2010).
Yacoby, I. & Benhar, I. Infect. Disord. Drug Targets 7, 221–229 (2007).
Conlon, B. P. et al. Nature 503, 365–370 (2013).
Kaiser, P. et al. PLoS Biol. 12, e1001793 (2014).
Porte, R. et al. Antimicrob. Agents Chemother. 59, 6064–6072 (2015).
Iwase, T. et al. Nature 465, 346–349 (2010).
Author information
Authors and Affiliations
Corresponding author
Related links
Rights and permissions
About this article
Cite this article
Hardt, WD. Homed to the hideout. Nature 527, 309–310 (2015). https://doi.org/10.1038/nature15647
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature15647
- Springer Nature Limited
This article is cited by
-
IL-33/ST2 immune responses to respiratory bacteria in pediatric asthma
Scientific Reports (2017)
-
Water-soluble benzylidene cyclopentanone based photosensitizers for in vitro and in vivo antimicrobial photodynamic therapy
Scientific Reports (2016)